Table A18:
Author, Year | Assessment Method | Outcome Definition | Time | Robot-Assisted Surgery | Laparoscopic Surgery | P Value |
---|---|---|---|---|---|---|
Randomized controlled trials | ||||||
Asimakopoulos et al, 201130 | Telephone interview | No leakage/need of any protective pad | 3 months | 69% | 63% | .51 |
6 months | 88% | 75% | .06 | |||
12 months | 94% | 83% | .07 | |||
— | Time to continence | — | 2.6 ± 4.2 months | 3.0 ± 2.9 months | .27 | |
Porpiglia et al, 201329 | Telephone interview | 0 or 1 pad/day | 3 months | 48/60 (80%) | 37/60 (62%) | .03 |
6 months | 53/60 (88%) | 44/60 (73%) | .04 | |||
12 months | 57/60 (95%) | 53/60 (83%) | .04 | |||
Nonrandomized studies | ||||||
Berge et al, 201358 | Mailed questionnaire | UCLA-PCI urinary function score | Baseline | 94.1 ± 11.0 | 92.4 ± 13.4 | — |
3 months | 62.1 ± 26.2 | 60.2 ± 27.2 | .9 | |||
12 months | 77.4 ± 22.4 | 78.5 ± 23.4 | .2 | |||
36 months | 77.0 ± 23.2 | 80.4 ± 22.7 | .06 | |||
Asimakopoulos et al, 201357 | Telephone interview | No leakage/need for any protective pad | 12 months | 123 (90%) | 74 (81%) | .05 |
Ploussard et al, 201460 | Mailed questionnaire | No pad usage | 3 months | 50% | 39% | .02 |
6 months | 72% | 59% | .02 | |||
12 months | 75% | 69% | .18 | |||
24 months | 84% | 79% | .02 | |||
Willis et al, 201261 | Questionnaire | 0 or 1 pad/day | Baseline | 99% | 100% | — |
3 months | 76% | 72% | .46 | |||
6 months | 87% | 89% | .67 | |||
12 months | 93% | 93% | .99 | |||
Questionnaire | EPIC urinary summary | Baseline | 90.3 ± 1.4 | 89.8 ± 11.7 | — | |
3 months | 76.6 ± 15.3 | 76.5 ± 14.4 | .96 | |||
6 months | 82.7 ± 14.9 | 83.4 ± 13.3 | .70 | |||
12 months | 83.5 ± 16.1 | 85.6 ± 13.4 | .25 |
Abbreviations: EPIC, Expanded Prostate Cancer Index Composite; UCLA-PCI, University of California–Los Angeles Prostate Cancer Index.